Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor suppressor p53 protein, encoded by the TP53 gene, is a critical transcription factor that maintains genomic stability and prevents cancer formation. It acts as a sequence-specific transcription factor, inducing growth arrest, apoptosis, or senescence depending on cellular stress. p53 is a modular protein with structured domains (DNA-binding, oligomerization) and unstructured regions at N-/C-terminals. Loss or mutation of functional p53 leads to unchecked cell division, a hallmark event in cancer development.
Activation of target genes involved in cell cycle arrest, DNA repair, apoptosis, and senescence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Suppressor p53 Protein (p53).